WallStSmart
MNMD

Mind Medicine Inc

NASDAQ: MNMD · HEALTHCARE · BIOTECHNOLOGY

$15.02
+1.01% today

Updated 2026-01-14

Market cap
$1.46B
P/E ratio
P/S ratio
EPS (TTM)
$-1.98
Dividend yield
52W range
$5 – $15
Volume
1.9M

Mind Medicine Inc (MNMD) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2015201620172018201920202021202220232024
Revenue$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$5500.00$6681.00$6683.00$2.62M$3.22M$3.16M$527000.00
Gross profit$-5500.00$-6681.00$-6683.00$-2.62M$-3.22M$-3.16M$-527000.00
Gross margin
R&D$18.63M$34.79M$36.17M$48.96M$65.30M
SG&A$1.35M$905661.00$506962.00$14.40M$59.06M$30.16M$41.74M$38.62M
Operating income$-94550.00$-111250.00$-1.24M$-861940.00$-468180.00$-33.03M$-93.85M$-66.33M$-93.87M$-103.92M
Operating margin
EBITDA$-92656.00$-111250.00$-1.51M$-851262.00$-1.11M$-32.29M$-91.24M$-63.15M$-92.57M$-105.87M
EBITDA margin
EBIT$-92656.00$-1.51M$-857943.00$-1.12M$-33.03M$-93.85M$-66.33M$-95.73M$-106.40M
Interest expense$0.00$0.00$0.00$164000.00$359000.00$1.50M$920000.00$2.28M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-92656.00$-179900.00$-1.23M$-857944.00$-1.12M$-34.10M$-93.04M$-56.80M$-95.73M$-108.68M
Net income growth (YoY)-94.2%-581.9%+30.1%-30.1%-2956.2%-172.8%+39.0%-68.6%-13.5%
Profit margin